D.1. Identify all factors and procedures that may adversely impact an animal’s wellbeing. (I think this is a drop down list. I may not have everything necessary included here).
Procedure Risk Factor
Blood/Body fluid collection Volume
Blood/Body fluid collection Frequency
Drug treatments Local and systemic effects
Drug treatments Frequency/total no. per animal
Tumour/Neoplasia induction Endpoint
Toxicology Substance
Toxicology Volume
Toxicology Endpoint/duration
Anaesthesia Induction – drug, dose, route
Anaesthesia Maintenance – drug, dose, route
Housing Duration held
D.2. for each factor identified – how to minimise adverse impact
Blood collection – volume/frequency: Blood will be collected at weekly intervals …show more content…
the separation of a bully from the remaining cage mates). The maximum holding times are set for each experimental type, i.e. 20 weeks for efficacy studies, up to 52 weeks for combination efficacy studies and the primary engraftment of patient biopsy samples. Environmental enrichment is provided by the addition of paper streamers (Alpha Twist) to the cage to allow for normal nesting behaviours and a transparent red igloo as a shelter/hiding place. Additionally sunflower seeds are given once per week as a nutritional supplement to the normal chow, but also as a source of enrichment that encourages species specific behaviours.
D.3.
For all experiments within the scope of this application there is an endpoint limit of 20% weight loss from the beginning of the experiment to ensure the animal’s well-being is not compromised. Additionally the threshold of event (25% human CD45+ cells) in the peripheral blood is set to allow the completion of efficacy experiments without extending the morbidity associated with leukaemia progression.
D.4. experiments with the potential for high impact on welfare
Toxicity testing, leukaemia engraftment and drug efficacy evaluation can potentially be high impact studies. There is also an expected incidence of thymoma and lymphoma in the NSG strain (could be up to 50% by 8.5 months of